Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations. - Wikidata - awgldk - TriplyDB

Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.

Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.

http://www.wikidata.org/entity/Q34084456

about

Five years of GWAS discovery Maturity-Onset Diabetes of the Young: What Do Clinicians Need to Know?Pathogenesis of the metabolic syndrome: insights from monogenic disorders Monogenic diabetes and pregnancy Undiagnosed MODY: Time for Action Hepatocyte Nuclear Factor 1A Is a Cell-Intrinsic Transcription Factor Required for B Cell Differentiation and Development in Mice Metabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkers Circulating CD36 is reduced in HNF1A-MODY carriers Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth.Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies Many faces of monogenic diabetes A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes.Low serum level of high-sensitivity C-reactive protein in a Japanese patient with maturity-onset diabetes of the young type 3 (MODY3).Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.MODY: history, genetics, pathophysiology, and clinical decision making.The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes.Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.Clinical features and treatment of maturity onset diabetes of the young (MODY).Using highly sensitive C-reactive protein measurement to diagnose MODY in a family with suspected type 2 diabetes Mutations in HNF1A result in marked alterations of plasma glycan profile Effects of hepatocyte nuclear factor-1A and -4A on pancreatic stone protein/regenerating protein and C-reactive protein gene expression: implications for maturity-onset diabetes of the young.Cystatin C is not a good candidate biomarker for HNF1A-MODY.Monogenic diabetes: a diagnostic algorithm for clinicians Mutations in PCBD1 cause hypomagnesemia and renal magnesium wasting.Type 2 diabetes and obesity: genomics and the clinic.The genetics of type 2 diabetes and its clinical relevance.When is it MODY? Challenges in the Interpretation of Sequence Variants in MODY Genes.Increased Oxidative Stress and Inflammation Independent of Body Adiposity in Diabetic and Nondiabetic Controls in falciparum Malaria.Clinical utility gene card for: Maturity-onset diabetes of the young.Comment on: McDonald et al. High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes. Diabetes Care 2011;34:1860-1862.RD Lawrence lecture 2012: assessing aetiology in diabetes: how C-peptide, CRP and fucosylation came to the party!Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.Response to Comment on: McDonald et al. High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes. Diabetes Care 2011;34:1860–1862.Can Biomarkers Help Target Maturity-Onset Diabetes of the Young Genetic Testing in Antibody-Negative Diabetes?Hepatocyte nuclear factors as possible C-reactive protein transcriptional inducer in the liver and white adipose tissue of rats with experimental chronic renal failure.Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort.Who should have genetic testing for maturity-onset diabetes of the young?HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.

P2860

Q24610574-B589546C-4B09-4674-88F7-E496F2FE7F06 Q26771916-F4C412A2-4466-4116-8F81-F87A39FBB013 Q27024024-7D233341-8C69-47DC-B9E5-4637CCC387EA Q28066434-670F2595-004A-46E9-A556-58D76B1B72A9 Q28083025-F243EFBF-19FD-4D47-B61E-19D65C3D7B48 Q28272446-2C5588E7-1017-4437-8101-84759B960A39 Q28481662-6176EE48-6956-49A8-8ACF-1B92BF39B156 Q28533348-C4CC28F9-2873-424E-A7A8-C0E5220DE319 Q30548217-90DFCF4D-AF1D-4C26-A496-75BF16E2BB7A Q31120060-63CE6BBA-041E-4FAD-B239-69F931D887A0 Q33622236-0CB524C2-CF8C-4150-9DCE-47F9E5FE0AAD Q34205887-C8953C25-5F74-4532-830F-0A276CD034D0 Q34299618-AA2EEC85-0511-4CB1-90A7-504C2B5D2B49 Q34322165-A7D38241-19D4-49BE-942E-780E4DA46B9B Q35123336-96C1AA6C-4253-4D6A-B710-F7B24775179C Q35123359-406011C8-5969-4BE4-A021-E1F8FEE6017B Q35894994-16C50139-8AFF-4F22-85CD-1F8FBEE3C39D Q35976364-3B4410C9-B4C6-4A0D-8CE2-7B4355878413 Q35997281-DD498425-1C71-4AE7-A300-CC1A20718B5D Q36157483-5AEA6B66-F470-4E28-BCF0-6DACC428C752 Q36720490-57AF4E0A-0E35-427C-9A18-7150084FD10E Q37000827-8E762017-195F-497D-9226-9DBBB7951B40 Q37501912-18AA29B2-4170-4548-9F9D-CC9149F635CB Q37590415-B4FBE338-D115-4F2C-A793-5CE60813882F Q37604723-35260243-85C6-49A3-B56F-8F064427D9E3 Q37885799-33320EA1-3401-466C-85FC-011974FBD6DC Q38061186-2A5FE046-5887-4401-B16A-14118664778A Q38816600-6D7EFEC5-E573-44EC-AAA2-E742A5F782AA Q42745697-2EAFF41A-1AF2-4370-8665-674803E3C2BB Q42796379-4407CB43-4A2C-42FD-9770-5100D99BC048 Q42974623-55BB9307-5448-49C4-B56C-A23F348D7266 Q43538580-3D2A4D7E-0916-41C0-B505-7C54728D3F95 Q43805190-0E894C96-7599-4FCC-8C42-EF7CA3F1EE4A Q45905297-98A090CA-B43D-4F00-8447-98CD7FF3723D Q49885981-4BF1D750-C0A6-4673-B061-E5DAB2CC0615 Q50057787-1FCB8BFC-147D-4D0E-91AD-2039D978E214 Q51291681-F72BE145-6CEF-4978-A83F-C0C63D8570A2 Q51869413-7D371CB7-5FB9-4DC4-8FF6-067D79B1245B Q54594220-332124F7-3062-41EE-99BD-270A9B41CB3D

P2860

Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.

http://www.wikidata.org/entity/Q34084456

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Assessment of high-sensitivity ...... young due to HNF1A mutations.

@ast

Assessment of high-sensitivity ...... young due to HNF1A mutations.

@en

Assessment of high-sensitivity ...... young due to HNF1A mutations.

@nl

type

label

Assessment of high-sensitivity ...... young due to HNF1A mutations.

@ast

Assessment of high-sensitivity ...... young due to HNF1A mutations.

@en

Assessment of high-sensitivity ...... young due to HNF1A mutations.

@nl

prefLabel

Assessment of high-sensitivity ...... young due to HNF1A mutations.

@ast

Assessment of high-sensitivity ...... young due to HNF1A mutations.

@en

Assessment of high-sensitivity ...... young due to HNF1A mutations.

@nl

P1433

Q34084456-E31F1BFC-6E57-420F-83DD-EC55384D3EF5

P1476

Q34084456-0F2E5F3E-F83B-40CA-8C55-9C3C428BD51E

P2093

Q34084456-291AE1D3-FEC0-4B7A-9412-951DA2EAAD75

Q34084456-3A8C4A3C-EC56-48CA-AB62-0C621B60DB86

Q34084456-48356074-24A9-44B2-A7B9-A2CCAB87C820

Q34084456-A7355815-B6F8-4F56-B430-1B3954EEA40E

P2860

Q34084456-039DADE6-EFCB-4C93-8D4E-82598DFDE424

Q34084456-1085B4AC-F5CA-4782-9C3D-326450DBB47F

Q34084456-1FC23E30-D728-42EA-9977-FF9285DB8DE5

Q34084456-2F31EF3C-4B64-494E-B57A-3212C0B80FC1

Q34084456-404F9293-3D19-467D-AA59-A79707FC2EB4

Q34084456-421D40EF-5D8A-47E3-B29F-E6F142B18D64

Q34084456-43E5CE9F-5B42-47B9-B5C2-E8ADD2524015

Q34084456-495888FC-AF78-4C7B-A458-B9E255BC1EF1

Q34084456-5166006F-B801-4F28-BEC3-EA2D73AEBFA0

Q34084456-560880C2-B96D-4AD9-9142-7F28B028E55A

P304

Q34084456-5D632025-8A0D-4ED1-B1C0-0FFC8FC14EE4

P31

Q34084456-0BDA17F9-1D7C-4F23-9926-8B180AC18C09

P356

Q34084456-C973F55C-C5C4-422F-8535-C65149AF3316

P407

Q34084456-7509FC86-1024-4C14-A895-EB35CDEF243E

P433

Q34084456-8F40381A-82B9-4736-A79C-A40B4DC69F9C

P478

Q34084456-138A37F0-9BAE-40B2-838A-CD8EF6E78238

P50

Q34084456-06AF2814-792B-42F8-B543-0E51E3094F90

Q34084456-1D843944-B39C-4CE6-9F6A-4600BFC41E17

Q34084456-B70AEC61-A9D0-4F48-9C3D-F4E0107EE51B

P577

Q34084456-4999FC45-3526-4892-B6F0-2FCAE768F0A1

P5875

Q34084456-34CA7F65-F65F-4CB4-8990-312719EA55FC

P698

Q34084456-FD49C6AC-B4B9-4980-8FD7-EE3F1D7ABB3D

P932

Q34084456-5E852483-D356-474B-8422-6DFE26DA394B

P356

P1433

P1476

Assessment of high-sensitivity ...... young due to HNF1A mutations.

@en

P2093

Andrew J Farmer

http://www.w3.org/2001/XMLSchema#string

Gaya Thanabalasingham

http://www.w3.org/2001/XMLSchema#string

Katharine R Owen

http://www.w3.org/2001/XMLSchema#string

Timothy J James

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels

Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism

Genetic cause of hyperglycaemia and response to treatment in diabetes

Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome

Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes

Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study

Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

A common haplotype of the glucokinase gene alters fasting glucose and birth weight: association in six studies and population-genetics analyses

Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young.

Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein.

P304

1919-1924

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC10-0288

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-08-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45721000

http://www.w3.org/2001/XMLSchema#string

P698

20724646

http://www.w3.org/2001/XMLSchema#string

P932

2928334

http://www.w3.org/2001/XMLSchema#string